Yahoo
NYSE - Delayed Quote USD

Medical Properties Trust, Inc. (MPT)

4.0100 -0.0300 (-0.74%)
At close: September 4 at 4:00:02 PM EDT
4.0299 +0.0199 (+0.50%)
After hours: 8:00:00 PM EDT
Trade MPT on Coinbase
Dividend
MPT announced a cash dividend of $0.09 with an ex-date of Sep. 10, 2026
Chart Range Bar
Loading chart for MPT

What's happening with MPT?

23m ago
Powered by Yahoo Scout

Medical Properties Trust (MPT) recently reported its Q2 2026 earnings, highlighting a major $2.4 billion refinancingthat aims to address upcoming debt maturities and enhance liquidity. Despite a net loss of $2.6 million, the company anticipates significant cash flow from planned asset sales.

Powered by Yahoo Scout
  • Previous Close 4.0400
  • Open 4.0400
  • Bid 4.0000 x 850000
  • Ask 3.9900 x 5340000
  • Day's Range 3.9600 - 4.0800
  • 52 Week Range 3.8900 - 6.4700
  • Volume 7,244,897
  • Avg. Volume 6,939,556
  • Market Cap (intraday) 2.395B
  • Beta (5Y Monthly) 1.44
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 0.36 (8.91%)
  • Ex-Dividend Date Sep 10, 2026
  • 1y Target Est 4.94

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception, the Company has grown to become one of the world's largest owners of hospital real estate with 378 facilities and approximately 38,000 licensed beds in nine countries and across three continents as of March 31, 2026. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Medical Properties Trust, Inc. is based in Alabama, Birmingham. Medical Properties Trust, Inc. was incorporated in 2003 in Maryland.

www.medicalpropertiestrust.com

121

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MPT
16.73%
S&P 500 (^GSPC)
12.75%

1-Year Return

MPT
3.20%
S&P 500 (^GSPC)
18.71%

3-Year Return

MPT
29.31%
S&P 500 (^GSPC)
70.93%

5-Year Return

MPT
71.77%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 259.28M
Earnings -2.6M
Profit Margin -1.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
-30.0%
-20.0%
-10.0%
0.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

3.80
4.94 Average
4.0100 Current
7.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/1/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Underweight
Price Action Lowers
Price Target 5 -> 3.8

Statistics

View More

Valuation Measures

Annual
As of 9/2/2026
  • Market Cap

    2.42B

  • Enterprise Value

    11.83B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.39

  • Price/Book (mrq)

    0.54

  • Enterprise Value/Revenue

    11.61

  • Enterprise Value/EBITDA

    11.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.73%

  • Return on Assets (ttm)

    2.77%

  • Return on Equity (ttm)

    -0.62%

  • Revenue (ttm)

    1.1B

  • Net Income Avi to Common (ttm)

    -31.6M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    396.56M

  • Total Debt/Equity (mrq)

    215.67%

  • Levered Free Cash Flow (ttm)

    753.95M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

4.0100 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • What does Argus have to say about MPT?

    Medical Properties Trust Inc has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about MPT?

    Medical Properties Trust Inc has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about MPT?

    Medical Properties Trust Inc has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target
  • Lowering target price to $3.00

    Medical Properties Trust Inc has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: